期刊文献+

基因转移技术现状及发展 被引量:2

下载PDF
导出
摘要 作为医学研究的重点课题,基因转移技术可以分为物理学法、化学法和生物学法三大类。本文阐明其中现有技术方法的原理,比较其特点及局限,并对其前景进行展望。
出处 《西部医学》 2008年第6期1288-1290,共3页 Medical Journal of West China
基金 第三军医大学校管基金资助项目(2006) 重庆市自然科学基金面上项目资助(CSTC 2006BB5063) 国家自然科学基金资助(No:39970269)
  • 相关文献

参考文献4

二级参考文献29

  • 1杨文博,孔佩艳,刘红,彭贤贵,常城,魏立,曾东风,刘林,陈幸华,王庆余.RNA干扰抑制基质细胞衍生因子-1基因的表达[J].免疫学杂志,2005,21(2):111-113. 被引量:1
  • 2Maeda T, Hobbs RM, Merghoub T, et al. Role of the protooncogene Pokemon in cellular transformation and ARF repression [J]. Nature,2005,433 (7 023):278 - 285.
  • 3Liu CJ, Prazak L, Fajardo M, et al. Leukemia/lymphomarelated factor, a POZ domain-containing transcriptional repressor, interacts with histone deacetylase-1 and inhibits cartilage oligomeric matrix protein gene expression and chondrogenesis [J]. J Biol Chem, 2004, 279(45): 47 081-47 091.
  • 4Lee DK, Suh D, Edenberg H J, et al. POZ domain transcription factor, FBI-1, represses transcription of ADH5/FDH by interacting with the zinc finger and interfering with DNA binding activity of Sp1 [J]. J Biol Chem, 2002, 277(30):26 761 - 26 768.
  • 5Laudes M, Christodoulides C, Sewter C, et al. Role of the POZ zinc finger transcription factor FBI-1 in human and murine adipogenesis [ J ]. J Biol Chem, 2004, 279 ( 12 ):11 711-11 718.
  • 6Pendergrast PS, Wang C, Hernandez N, et al. FBI-1 can stimulate HIV-1 Tat activity and is targeted to a novel subnuclear domain that includes the Tat-P-TEFb--containing nuclear speckles [J]. Mol Biol Cell, 2002, 13(3) :915 - 929.
  • 7HannonGJ. RNAinterference [ J ]. Nature ,2002,418(6 894):244 - 251.
  • 8Stevenson M. Therapeutic potential of RNA interference[J].N Engl J Med, 2004, 351(17):1 772- 1 777.
  • 9Oligino TJ, Yao QP, Ghivizzani SC, et al. Vector systems for gene transfer to joints [J]. Clin Orthop, 2000, 379 (Supp1): S17 - S30.
  • 10Tachibana K, Uchida T, Ogawa K, Yamashita N. Tamura K. Induction of cell-membrane porosity by ultrasound. Lancet. 1999, 353:1409-1411

共引文献21

同被引文献23

  • 1周骏宇.品牌的进化[J].企业管理,2006(11):24-25. 被引量:6
  • 2杨金勇,黄克正,尚勇,李长江.产品基因研究综述[J].机械设计,2007,24(4):1-4. 被引量:22
  • 3Pouton CW,Seymour LW.Key issues in non-viral gene delivery[J].Adv Drug Deliv Rev,2001,46(2):187.
  • 4Jarver P,Lange I U.The use of cell-penetrating peptides as a tool for gene regulation[J].Drug Discov Today,2004,9(9):395-402.
  • 5Tsai JT,Furstoss KJ,Michnick T,et al.Quantitative physical characterization of lipid-polycation-DNA lipopolyplexes[J].Biotechnol Appl Biochem,2002,36(1):13.
  • 6Li S,Rizzo MA,Bhattacharya S,et al.Characterization of cationic lipid-protamine-DNA(LPD)complexes for intravenous gene delivery[J].Gene Therapy,1998,5(8):930.
  • 7Arangoa MA,Düzgünes N,Ilarduya CT.Increased receptor-mediated gene delivery to the liver by protamine-enhanced-asialofetuin-lipoplexes[J].Gene Therapy,2003,10(1):5.
  • 8Schwarze SR,Ho A,Vecero-Akbani A,et al.In vivo protein transduction:delivery of a biologically active protein into the mouse[J].Science,1999,285(5433):1569-1572.
  • 9Matsui H,Tomizawa K,Matsushita M.Protein transduction by poly-arginine[J].Nippon Yakurigaku Zasshi,2003,121(6):435-439.
  • 10Kalderon D,Richardson W D,Markham A F,et al.Sequence requirements for nuclear location of simian virus 40 large-Tantigen[J].Nature,1984,311:33-38.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部